The OPEN MINDS Executive Blueprint for Crisis ManagementBuilding Organizational Sustainability & Success in a Disrupted Health & Human Service Market
A 32-week program designed to help executive teams navigate the business, organizational, operational, and culture changes of a market in turbulence. The program, based on the seven-component OPEN MINDS executive blueprint, combines a series of 35 live educational web briefings with online technical assistance and a suite of on-demand resources.
On November 20, 2019, the U.S. Food and Drug Administration sent a warning letter to RichSource Stem Cells, Inc. The warning letter outlines a review conducted by the Office of Compliance and Biologics Quality in the Center for Biologics Evaluation and Research, noting that RICHGEN appears to be a human cell, tissue, or cellular or tissue-based product currently not meeting the criteria outlined in 21 CFR 1271.15 . . .